Analysis of the Effect of Trastuzumab Combined with Docetaxel on Serum Tumor Markers in the Treatment of HER-2 Positive Breast Cancer and Factors Influencing Therapeutic Efficacy

OBJECTIVE: To explore the influence of trastuzumab (TZ) combined with docetaxel (DTX) on serum tumor markers (TMs) in the treatment of human epidermal growth factor receptor 2-positive (HER-2+) breast cancer (BC) and to analyze the factors influencing therapeutic efficacy. METHODS: Ninety-six patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qi-Zhu, Chen, Xian-Zhi, Sun, Jie, Lu, Man-Man, Wang, Yong, Wang, Qi, Zhang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559233/
https://www.ncbi.nlm.nih.gov/pubmed/34737636
http://dx.doi.org/10.2147/CMAR.S334680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559233/
https://www.ncbi.nlm.nih.gov/pubmed/34737636
http://dx.doi.org/10.2147/CMAR.S334680

Ejemplares similares